Stumps 
Sector : Pharmaceuticals
BSE
1119.65 3.36%
NSE
1119.60 3.31 %
Nov 16, 12:55
Ajanta Pharma climbs 5% on USFDA approval for generic of Vesicare
Oct 31, 17:48
Ajanta Pharma Standalone September 2018 Net Sales at Rs 465.29 crore, down 0.82% Q-o-Q
Oct 31, 17:46
Oct 12, 15:36
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct
Nov 16, 16:00
Price
BSE
1119.65 3.36%
NSE
1119.60 3.31%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
